Table 1 Clinical characteristics of the patients
OIQ Total Score | Gender, F(%) | Age | Height (cm) | Weight (kg) | BMI | Max HR Increment | BDI-II | PCS | MCS |
|---|---|---|---|---|---|---|---|---|---|
Total (n = 107) | 67 (62.6%) | 31.1 ± 1.3 | 166.3 ± 0.9 | 62.2 ± 1.3 | 22.3 ± 0.3 | 42.8 ± 1.2 | 14.8 ± 0.8 | 43.4 ± 0.8 | 39.9 ± 1.1 |
 0–4 (n = 16) | 7 (43.8%) | 23.6 ± 3.0 | 169.2 ± 2.3 | 63.7 ± 2.8 | 22.2 ± 0.7 | 46.4 ± 3.0 | 7.4 ± 1.0 | 49.6 ± 2.2 | 46.9 ± 2.6 |
 5–9 (n = 15) | 9 (60%) | 30.5 ± 2.4 | 168.8 ± 2.6 | 65.4 ± 3.9 | 22.7 ± 0.9 | 38.9 ± 3.0 | 10.2 ± 1.6 | 49.0 ± 1.7 | 45.4 ± 2.1 |
 10–14 (n = 21) | 13 (61.9%) | 34.7 ± 4.0 | 168.5 ± 2.5 | 64.2 ± 3.6 | 22.4 ± 0.8 | 45.9 ± 2.9 | 13.3 ± 1.9 | 42.4 ± 1.3 | 41.0 ± 2.1 |
 15–19 (n = 25) | 16 (64%) | 32.2 ± 2.3 | 165.2 ± 1.9 | 62.2 ± 3.1 | 22.6 ± 0.8 | 43.2 ± 2.8 | 17.2 ± 1.6 | 42.2 ± 1.3 | 38.8 ± 1.8 |
 20–24 (n = 17) | 14 (82.4%) | 33.1 ± 2.3 | 161.5 ± 1.6 | 58.4 ± 2.4 | 22.4 ± 0.8 | 37.2 ± 1.5 | 19.1 ± 2.0 | 40.7 ± 1.5 | 35.9 ± 1.9 |
 25–29 (n = 4) | 4 (100%) | 25.3 ± 3.2 | 160.1 ± 4.5 | 55.2 ± 4.9 | 21.4 ± 1.1 | 42.0 ± 4.6 | 21.8 ± 2.8 | 39.3 ± 3.7 | 29.7 ± 2.0 |
 30–34 (n = 6) | 3 (50%) | 32.5 ± 6.3 | 167.8 ± 3.6 | 60.7 ± 4.3 | 21.5 ± 1.2 | 47.7 ± 3.9 | 21.5 ± 3.5 | 36.9 ± 2.2 | 30.1 ± 8.3 |
 35–39 (n = 3) | 1 (33.3%) | 33.7 ± 8.8 | 164.9 ± 4.2 | 57.1 ± 5.4 | 20.9 ± 1.2 | 40.0 ± 6.2 | 21.0 ± 4.9 | 32.3 ± 6.7 | 33.5 ± 10.1 |
  P value (Kruskall-Wallis) |  | 0.047 | 0.211 | 0.81 | 0.984 | 0.1 | <0.001* | <0.001* | <0.001* |